fenofibrate (Antara, Fenoglide, Fibricor, Lipofen, Lofibra, Tricor, Triglide, Trilipix)
Title: fenofibrate (Antara, Fenoglide, Fibricor, Lipofen, Lofibra, Tricor, Triglide, Trilipix)Category: MedicationsCreated: 3/2/2005 12:00:00 AMLast Editorial Review: 11/11/2014 12:00:00 AM (Source: MedicineNet Cholesterol General)
Source: MedicineNet Cholesterol General - November 11, 2014 Category: Cardiology Source Type: news

Ranbaxy Laboratories gets USFDA nod to sell cholesterol medicine
Ranbaxy received approval from USFDA to manufacture & market Fenofibrate capsules used for lowering high cholesterol & triglyceride levels in blood. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 5, 2014 Category: Pharmaceuticals Source Type: news

Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now...
LifeScienceIndustryResearch.com adds Latest Report on “Market Research Report on Global and Chinese Fenofibrate (CAS 49562-28-9) Industry, 2009-2019” to its store. Inquire Before Buying at...(PRWeb September 21, 2014)Read the full story at http://www.prweb.com/releases/fenofibrate-market/2009-2019/prweb12184231.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 21, 2014 Category: Pharmaceuticals Source Type: news

Fibrate Seems to Reduce CVD Risk in Diabetic Women
(MedPage Today) -- Contrary to earlier results, fenofibrate may actually lower cardiovascular risk in women with type 2 diabetes, researchers found. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 19, 2014 Category: Cardiology Source Type: news

Fenofibrate also effective for women with type 2 diabetes
Blood-fat lowering drug fenofibrate is beneficial for women with type 2 diabetes, according to new research. (Source: Nursing Times Breaking News)
Source: Nursing Times Breaking News - August 19, 2014 Category: Nursing Source Type: news

Fenofibrate Works as Well in Women With Diabetes as in MenFenofibrate Works as Well in Women With Diabetes as in Men
Fenofibrate appears to work as well in women with type 2 diabetes as in men, according to a new FIELD analysis, providing reassurance after the ACCORD Lipid trial. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 18, 2014 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Fenofibrate and Renal DiseaseFenofibrate and Renal Disease
Find out more about the potentially cardioprotective effects of fenofibrate for patients with type 2 diabetes. Clinical Lipidology (Source: Medscape Nephrology Headlines)
Source: Medscape Nephrology Headlines - January 11, 2014 Category: Urology & Nephrology Tags: Cardiology Journal Article Source Type: news

HDL-C Lowering Seen in Some Patients on Fibrate/TZD ComboHDL-C Lowering Seen in Some Patients on Fibrate/TZD Combo
Data from the ACCORD trial suggest that in a small number of patients, perhaps with a particular genetic background, the combination of fenofibrate and a TZD dramatically lowers HDL cholesterol. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 9, 2013 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Odd HDL Finding Seen in Diabetes Trial (CME/CE)
(MedPage Today) -- Among patients with type 2 diabetes, treatment with both fenofibrate and a thiazolidinedione was paradoxically tied to a higher likelihood of having an extremely low HDL cholesterol level, researchers found. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - December 4, 2013 Category: Cardiology Source Type: news

World First Approval for Fenofibrate in Diabetic RetinopathyWorld First Approval for Fenofibrate in Diabetic Retinopathy
The established cholesterol-lowering drug fenofibrate has received first approval globally to slow the progression of diabetic retinopathy in patients with type 2 diabetes in Australia. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 29, 2013 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Fish Oil vs. Drugs for Hypertriglyceridemia in HIV+ PatientsFish Oil vs. Drugs for Hypertriglyceridemia in HIV+ Patients
Is fish oil as effective as fenofibrate, gemfibrozil, and atorvastatin in reducing triglyceride levels in HIV patients? JAIDS: Journal of Acquired Immune Deficiency Syndromes (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 8, 2013 Category: Consumer Health News Tags: HIV/AIDS Journal Article Source Type: news

Antara (Fenofibrate) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 4, 2013 Category: Drugs & Pharmacology Source Type: news

EMA Panel Gives Thumbs-up to Fenofibrate/Simvastatin ComboEMA Panel Gives Thumbs-up to Fenofibrate/Simvastatin Combo
The drug, known as Cholib, received a "positive opinion" from CHMP for two doses of the fenofibrate/simvastatin combination. A positive opinion is a prerequisite to approval by the European Commission, which has 67 days from the date of the opinion to grant approval. International Approvals (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - June 28, 2013 Category: Cardiology Tags: Cardiology News Alert Source Type: news

EMA advisory committee gives thumbs-up to fenofibrate/simvastatin combo
The drug, known as Cholib, received a "positive opinion" from CHMP for two doses of the fenofibrate/simvastatin combination. A positive opinion is a prerequisite to approval by the European Commission, which has 67 days from the date of the opinion to grant approval. (Source: theHeart.org)
Source: theHeart.org - June 28, 2013 Category: Cardiology Source Type: news

Mylan Launches Generic Antara® Capsules
Mylan Inc. (Nasdaq:MYL) today announced that its subsidiary Mylan Pharmaceuticals has begun shipping Fenofibrate Capsules USP, 43 mg and 130 mg. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - February 26, 2013 Category: Pharmaceuticals Source Type: news